Mina Alpha Limited
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone (NCT04710641) | Mina Alpha Limited | 2022-01-01 |
| A Study of MTL-CEBPA in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumours (TIMEPOINT) (NCT04105335) | Mina Alpha Limited | 2019-11-13 |
Track Mina Alpha Limited automatically
Every clearance here is in the API, with alerts when new ones post.